Class IITerminatedD-0283-2022
Drug recall · December 22, 2021
Methylcobalamin 12mg/ml injection recall
Why: Lack of Processing Controls
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
- Lots / codes
Lot #: 188008, BUD 03/19/2022
- Quantity
- 27 vials
- Company
- Valgene Incorporated dba Cape Drugs, Annapolis, MD
- Distribution
- Maryland Only
- Initiated
- December 3, 2021 · Voluntary: Firm initiated
- Classified
- December 15, 2021
- Reported
- December 22, 2021
- Ended
- January 4, 2022
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.